FATE THERAPEUTICS, INC. (FATE) Free cash flow 2016–2025
FATE THERAPEUTICS, INC. (FATE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$112.0MFY2025 · since FY2016: -$30.3M → -$112.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$112.0M | +9.4% |
| FY2024 | -$123.6M | +10.7% |
| FY2023 | -$138.4M | +51.2% |
| FY2022 | -$283.8M | -32.9% |
| FY2021 | -$213.6M | -383.6% |
| FY2020 | -$44.2M | +51.2% |
| FY2019 | -$90.6M | -121.2% |
| FY2018 | -$41.0M | -6.3% |
| FY2017 | -$38.5M | -27.3% |
| FY2016 | -$30.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice